Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Resverlogix Corp. RVXCF


Primary Symbol: T.RVX Alternate Symbol(s):  T.RVX.W.A

Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.


Company Profile & Information (OTCPK:RVXCF)

Showcase News Releases

Showcase news

P Squared Renewables Inc.
Universal Ibogaine Provides Update on Kelburn Recovery Center
Prospera Energy Inc
Prospera Energy Inc. Announces Milestone Q2 2022 Revenue (Increase of 860% over Q2 2021)
Saturn Oil & Gas Inc.
Saturn Oil & Gas Inc. Reports Q2 2022 Financial and Operational Results Highlighted by Record Quarterly Cash Flow

More Showcase News Releases »